|
[1] JIANG HQ,ZHANG XL. Pathogenesis of liver fibrosis[J]. World Chin J Dig,2000,8(6):687-689.(in Chinese)姜慧卿，张晓岚．肝纤维化的发生机制[J]．世界华人消化杂志，2000,8(6):687-689.
|
|
[2] ZHAO Z,LIN CY,CHENG K. siRNA-and miRNA-based therapeutics for liver fibrosis[J]. Transl Res,2019,214:17-29.
|
|
[3] GAO Q,LI XG,FAN L,et al. Research progress in pathogenesis of liver fibrosis[J]. Prog Mod Biomed,2017,17(14):2780-2785,2677.(in Chinese)高强，李旭光，樊莉，等．肝纤维化发病机制的研究进展[J]．现代生物医学进展，2017,17(14):2780-2785,2677.
|
|
[4] TAO KG,LIN Y. Research progress of long non coding RNA regulating hepatic fibrosis signal pathway[J]. Chin J Gastroenter,2019,24(11):688-690.(in Chinese)陶科攻，林勇．长链非编码RNA调控肝纤维化信号通路的研究进展[J]．胃肠病学，2019,24(11):688-690.
|
|
[5] WANG Y,GUO T,LI JH,et al. Biological function and regulatory mechanism of epithelial-mesenchymal transition-related long non-coding RNAs in liver cancer[J]. J Clin Hepatol,2019,35(3):656-660.(in Chinese)王元，郭涛，李靖华，等．上皮-间质转化相关长链非编码RNA在肝癌中的生物学功能及调控机制[J]．临床肝胆病杂志，2019,35(3):656-660.
|
|
[6] XING YH,CHEN LL. Processing and roles of snoRNA-ended long noncoding RNAs[J]. Crit Rev Biochem Mol Biol,2018,53(6):596-606.
|
|
[7] LI R,WANG T,ZHU HL. Biological functions and research methods of long non coding RNA[J]. China Biotechnol,2015,35(9):66-70.(in Chinese)李冉，王恬，朱鸿亮．长链非编码RNA的生物学功能和研究方法[J]．中国生物工程杂志，2015,35(9):66-70.
|
|
[8] SPENCER HL,SANDERS R,BOULBERDAA M,et al. The LINC00961 transcript and its encoded micropeptide,small regulatory polypeptide of amino acid response,regulate endothelial cell function[J]. Cardiovasc Res,2020,116(12):1981-1994.
|
|
[9] RANSOHOFF JD,WEI Y,KHAVARI PA. The functions and unique features of long intergenic non-coding RNA[J]. Nat Rev Mol Cell Biol,2018,19(3):143-157.
|
|
[10] WANG KC,CHANG HY. Molecular mechanisms of long noncoding RNAs[J]. Mol Cell,2011,43(6):904-914.
|
|
[11] DHANOA JK,SETHI RS,VERMA R,et al. Long non-coding RNA:Its evolutionary relics and biological implications in mammals:A review[J]. J Anim Sci Technol,2018,60:25.
|
|
[12] SANBONMATSU KY. Towards structural classification of long non-coding RNAs[J]. Biochim Biophys Acta,2016,1859(1):41-45.
|
|
[13] JIN Q,ZHAO Z,ZHAO Q,et al. Long noncoding RNAs:Emerging roles in pulmonary hypertension[J]. Heart Fail Rev,2020,25(5):795-815.
|
|
[14] PONTING CP,OLIVER PL,REIK W. Evolution and functions of long noncoding RNAs[J]. Cell,2009,136(4):629-641.
|
|
[15] ZHU J,YU W,WANG Y,et al. lncRNAs:Function and mechanism in cartilage development,degeneration,and regeneration[J]. Stem Cell Res Ther,2019,10(1):344.
|
|
[16] HE Y,WU YT,HUANG C,et al. Inhibitory effects of long noncoding RNA MEG3 on hepatic stellate cells activation and liver fibrogenesis[J]. Biochim Biophys Acta,2014,1842(11):2204-2215.
|
|
[17] YU F,ZHENG J,MAO Y,et al. Long non-coding RNA growth arrest-specific transcript 5(GAS5)inhibits liver fibrogenesis through a mechanism of competing endogenous RNA[J]. J Biol Chem,2015,290(47):28286-28298.
|
|
[18] ZHENG J,DONG P,MAO Y,et al. lincRNA-p21 inhibits hepatic stellate cell activation and liver fibrogenesis via p21[J].FEBS J,2015,282(24):4810-4821.
|
|
[19] YU F,LU Z,CAI J,et al. MALAT1 functions as a competing endogenous RNA to mediate Rac1 expression by sequestering miR-101b in liver fibrosis[J]. Cell Cycle,2015,14(24):3885-3896.
|
|
[20] FU N,NIU X,WANG Y,et al. Role of LncRNA-activated by transforming growth factor beta in the progression of hepatitis C virus-related liver fibrosis[J]. Discov Med,2016,22(119):29-42.
|
|
[21] ZHENG J,YU F,DONG P,et al. Long non-coding RNA PVT1 activates hepatic stellate cells through competitively binding microRNA-152[J]. Oncotarget,2016,7(39):62886-62897.
|
|
[22] BIAN EB,WANG YY,YANG Y,et al. Hotair facilitates hepatic stellate cells activation and fibrogenesis in the liver[J]. Biochim Biophys Acta Mol Basis Dis,2017,1863(3):674-686.
|
|
[23] ZHU J,LUO Z,PAN Y,et al. H19/miR-148a/USP4 axis facilitates liver fibrosis by enhancing TGF-βsignaling in both hepatic stellate cells and hepatocytes[J]. J Cell Physiol,2019,234(6):9698-9710.
|
|
[24] YU F,DONG P,MAO Y,et al. Loss of lncRNA-SNHG7 promotes the suppression of hepatic stel ate cell activation via miR-378a-3p and DVL2[J]. Mol Ther Nucleic Acids,2019,17:235-244.
|
|
[25] ZHANG ZF,LI H,DENG XX,et al. Research progress on the relationship between non coding RNA and liver fibrosis[J].Guangdong Med J,2019,40(17):2547-2553.(in Chinese)张泽凤，李晖，邓秀秀，等．非编码RNA与肝纤维化相关性研究进展[J]．广东医学，2019,40(17):2547-2553.
|
|
[26] YU F,GENG W,DONG P,et al. LncRNA-MEG3 inhibits activation of hepatic stellate cells through SMO protein and miR-212[J]. Cell Death Dis,2018,9(10):1014.
|
|
[27] WANG M,GUO C,WANG L,et al. Long noncoding RNA GAS5 promotes bladder cancer cells apoptosis through inhibiting EZH2 transcription[J]. Cell Death Dis,2018,9(2):238.
|
|
[28] LIU L,PANG X,SHANG W,et al. Long non-coding RNA GAS5 sensitizes renal cell carcinoma to sorafenib via miR-21/SOX5 pathway[J]. Cell Cycle,2019,18(3):257-263.
|
|
[29] LI W,ZHAO W,LU Z,et al. Long noncoding RNA GAS5 promotes proliferation,migration,and invasion by regulation of miR-301a in esophageal cancer[J]. Oncol Res,2018,26(8):1285-1294.
|
|
[30] DONG Z,LI S,WANG X,et al. lncRNA GAS5 restrains CCl4-induced hepatic fibrosis by targeting miR-23a through the PTEN/PI3K/Akt signaling pathway[J]. Am J Physiol Gastrointest Liver Physiol,2019,316(4):G539-G550.
|
|
[31] HUARTE M,GUTTMAN M,FELDSER D,et al. A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response[J]. Cell,2010,142(3):409-419.
|
|
[32] YU F,LU Z,CHEN B,et al. Identification of a novel lincRNAp21-miR-181b-PTEN signaling cascade in liver fibrosis[J].Mediators Inflamm,2016,2016:9856538.
|
|
[33] WU Y,LIU X,ZHOU Q,et al. Silent information regulator 1(SIRT1)ameliorates liver fibrosis via promoting activated stellate cell apoptosis and reversion[J]. Toxicol Appl Pharmacol,2015,289(2):163-176.
|
|
[34] FU N,ZHAO SX,KONG LB,et al. LncRNA-ATB/microRNA-200a/β-catenin regulatory axis involved in the progression of HCV-related hepatic fibrosis[J]. Gene,2017,618:1-7.
|
|
[35] GUO J,HAO C,WANG C,et al. Long noncoding RNA PVT1modulates hepatocellular carcinoma cell proliferation and apoptosis by recruiting EZH2[J]. Cancer Cell Int,2018,18:98.
|
|
[36] CHEN J,YU Y,LI H,et al. Long non-coding RNA PVT1 promotes tumor progression by regulating the miR-143/HK2 axis in gallbladder cancer[J]. Mol Cancer,2019,18(1):33.
|
|
[37] YANG Q,YU Y,SUN Z,et al. Long non-coding RNA PVT1 promotes cell proliferation and invasion through regulating miR-133a in ovarian cancer[J]. Biomed Pharmacother,2018,106:61-67.
|
|
[38] IULIANELLA A,STANTON-TURCOTTE D. The Hedgehog receptor Patched1 regulates proliferation, neurogenesis, and axon guidance in the embryonic spinal cord[J]. Mech Dev,2019,160:103577.
|
|
[39] FU C,LI D,ZHANG X,et al. LncRNA PVT1 facilitates tumorigenesis and progression of glioma via regulation of MiR-128-3p/GREM1 axis and BMP signaling pathway[J]. Neurotherapeutics,2018,15(4):1139-1157.
|
|
[40] XUE W,CHEN J,LIU X,et al. PVT1 regulates the malignant behaviors of human glioma cells by targeting miR-190a-5p and miR-488-3p[J]. Biochim Biophys Acta Mol Basis Dis,2018,1864(5 Pt A):1783-1794.
|
|
[41] XIAO Y,LIU R,LI X,et al. Long noncoding RNA H19 contributes to cholangiocyte proliferation and cholestatic liver fibrosis in biliary atresia[J]. Hepatology,2019,70(5):1658-1673.
|
|
[42] YAN XB,SUN YK,TANG CX. Long non coding-RNA H19promotes cholangiocyte proliferation and cholestatic hepatic fibrosis in biliary atresia[J]. J Clin Hepatol,2019,35(6):1396.(in Chinese)颜学波，孙永康，唐才喜．长链非编码RNA H19在胆道闭锁中促进胆管细胞增殖和胆汁淤积性肝纤维化[J]．临床肝胆病杂志，2019,35(6):1396.
|
|
[43] SHE KL,YAN H,HUANG J,et al. miR-193b availability is antagonized by LncRNA-SNHG 7 for FAIM 2-induced tumour progression in non-small cell lung cancer[J]. Cell Proliferation,2018,51(1):e12406.
|
|
[44] ZHONG X,LONG Z,WU S,et al. LncRNA-SNHG7 regulates proliferation,apoptosis and invasion of bladder cancer cells assurance guidelines[J]. J BUON,2018,23(3):776-781.
|
|
[45] QI H,WEN B,WU Q,et al. Long noncoding RNA SNHG7 accelerates prostate cancer proliferation and cycle progression through cyclin D1 by sponging miR-503[J]. Biomed Pharmacother,2018,102:326-332.
|
DownLoad: